Phfr, Inc. is targeting treatments aimed at nerve cell membranes, the communication centers of the brain, and energy production essential in maintaining the normal function of key membrane processes, in order to prevent psychiatric disorders, such as Alzheimerâs disease, autism, chronic alcoholism, major depressive disorders, and schizophrenia, including recurrent depression and manic-depressive disorders, present with behavioral, cognitive, and mood symptoms.
Therapeutic approaches have historically, even to this present time, been focused on exclusively treating symptoms. Unfortunately, this approach is insufficient, as by the time symptoms appear, changes at a molecular and cellular level have occurred for a long time â in some cases, such as Alzheimer's disease, decades. Therefore, it is vitally important to treat more fundamental molecular and cellular causes of symptoms with the goal of preventing further progression of disease.
